At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,112 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Key inclusion· 2
- ✓Diagnosis of renal cell carcinoma (RCC) between 01 January 2010 and 31 December 2021
- ✓Evidence of metastatic RCC: ICD-10 metastasis code (C77–C79), AJCC stage 4, oncology visit with RCC as main diagnosis, or treatment initiation for mRCC
Key exclusion· 3
- ✕Prevalent mRCC diagnosed before 01 January 2010
- ✕RCC diagnosed before 01 January 2010 with no records of metastatic disease during 2010–2021
- ✕No treatment initiated for mRCC
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Registry-based Non-interventional Analysis of Advanced/Metastatic Renal Carcinoma Treatment Patterns and Outcomes in the Hospital District of Southwest Finland.
In Brief
An observational study for Renal Cell Cancer and 6 related conditions. Completed, enrolled 1,112 participants across 1 site.
Detailed Summary
The purpose of the study is to find out how patients with advanced kidney cancer have been treated in the hospital district of Southwest Finland over time.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRenal Cell Cancer, Renal Cell Carcinoma, Cancer of Kidney, Cancer of the Kidney, Kidney Cancer, Kidney Neoplasms, Renal Cancer
CountriesFinland
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartMay 2022
First PostedMay 2022
Primary CompletionJun 2022
TodayJul 2026
First PostedMay 5, 2022
Enrollment StartMay 2, 2022
Primary CompletionJun 8, 2022
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 4.2 years ago